Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSGeneric

TREANDA

BENDAMUSTINE HYDROCHLORIDE

Standard Dose
180MG/2ML (90MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview TREANDA is listed in Drugs@FDA under application 022249 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient BENDAMUSTINE HYDROCHLORIDE Form and strength SOLUTION;INTRAVENOUS - 180MG/2ML (90MG/ML) Sponsor CEPHALON Submission history Latest submission status date: 2022-10-25 00:00:00.

Structured Monograph

Clinical summary

Approval overview TREANDA is listed in Drugs@FDA under application 022249 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient BENDAMUSTINE HYDROCHLORIDE Form and strength SOLUTION;INTRAVENOUS - 180MG/2ML (90MG/ML) Sponsor CEPHALON Submission history Latest submission status date: 2022-10-25 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.